{"status":"ok","message-type":"event-list","message":{"next-cursor":"f82ee369-4d35-4bd1-9cd4-530937ab7ccd","total-results":62,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2017-05-29T23:06:38Z","subj_id":"http:\/\/twitter.com\/emeKato\/statuses\/869329162191880192","id":"3d23d358-d0c6-488e-b491-fa241ac912dd","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20170529-twitter-3bce6256-de55-4051-9170-e144c8f9dfe7","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"http:\/\/twitter.com\/emeKato\/statuses\/869329162191880192","title":"Tweet 869329162191880192","issued":"2017-05-29T23:06:38.000Z","author":{"url":"http:\/\/www.twitter.com\/emeKato"},"original-tweet-url":"http:\/\/twitter.com\/emeKato\/statuses\/869329162191880192","original-tweet-author":null,"alternative-id":"869329162191880192"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1002\/bit.1179","url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bit.1179\/abstract"},"timestamp":"2017-05-29T23:07:03Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2008-05-13T00:00:00Z","subj_id":"https:\/\/lens.org\/102-981-876-957-480","id":"67ace26b-14fe-b5db-359e-4b9ddbe0e576","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Gene Expression System","pid":"https:\/\/lens.org\/102-981-876-957-480","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T01:07:55Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-07T00:00:00Z","subj_id":"https:\/\/lens.org\/109-804-121-390-735","id":"9e6f2d05-f405-ec0b-b7ef-7e52b3430d39","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Chimeric Anti-Vegf-D Antibodies And Humanized Anti-Vegf-D Antibodies And Methods Of Using Same","pid":"https:\/\/lens.org\/109-804-121-390-735","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T02:53:43Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-12-13T00:00:00Z","subj_id":"https:\/\/lens.org\/112-299-277-109-966","id":"83e2d91d-72b9-82a5-4067-7f7e95172a3a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Processes And Compositions For Transfecting Chinese Hamster Ovary (Cho) Cells","pid":"https:\/\/lens.org\/112-299-277-109-966","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T03:32:32Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-07-18T00:00:00Z","subj_id":"https:\/\/lens.org\/117-119-152-649-345","id":"e54f3f83-9605-5b38-0d50-3b1e57c0c1f6","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Rodent Expression Systems Utilising Polyoma Virus And Epstein Barr Virus Sequences","pid":"https:\/\/lens.org\/117-119-152-649-345","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-10T04:47:13Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-10-05T00:00:00Z","subj_id":"https:\/\/lens.org\/118-148-404-787-138","id":"f3a12989-7ede-b480-0509-cac734622ba9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Method For The Recombinant Expression Of A Polypeptide","pid":"https:\/\/lens.org\/118-148-404-787-138","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:02:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-14T00:00:00Z","subj_id":"https:\/\/lens.org\/011-816-880-968-213","id":"df803b07-c805-2638-89e0-c4dc4e62ca84","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Specific Sites For Modifying Antibodies To Make Immunoconjugates","pid":"https:\/\/lens.org\/011-816-880-968-213","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:03:08Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-02-09T00:00:00Z","subj_id":"https:\/\/lens.org\/119-080-177-526-699","id":"12fd2659-2123-6d6d-584f-e2f596d4d23e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-Mhc Antibody Anti-Viral Cytokine Fusion Protein","pid":"https:\/\/lens.org\/119-080-177-526-699","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:17:15Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-09-14T00:00:00Z","subj_id":"https:\/\/lens.org\/119-902-431-325-172","id":"aa821369-a690-291a-d0a2-f89def08673c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Methods And Materials For Expression Of A Recombinant Protein","pid":"https:\/\/lens.org\/119-902-431-325-172","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:30:11Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-07-31T00:00:00Z","subj_id":"https:\/\/lens.org\/120-689-513-106-892","id":"441f26fe-c978-32a4-aeda-63362a94d8f2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Rationally Designed Media For Cell Culture","pid":"https:\/\/lens.org\/120-689-513-106-892","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T05:42:14Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-06-25T00:00:00Z","subj_id":"https:\/\/lens.org\/127-414-117-674-099","id":"707b1bec-716a-2efa-993a-1806c8d62f9d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Humanized Anti-Tau(Ps422) Antibodies And Methods Of Use","pid":"https:\/\/lens.org\/127-414-117-674-099","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T07:25:37Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2013-07-23T00:00:00Z","subj_id":"https:\/\/lens.org\/134-364-007-255-660","id":"ac3feba0-797d-0ff2-9ccf-52c7e54d3fed","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Processes And Compositions For Transfecting Chinese Hamster Ovary (Cho) Cells","pid":"https:\/\/lens.org\/134-364-007-255-660","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T09:13:45Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-02-15T00:00:00Z","subj_id":"https:\/\/lens.org\/137-945-729-039-956","id":"0b8e54ab-8135-92d5-7b71-a344016703f8","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Methods And Materials For Expression Of A Recombinant Protein","pid":"https:\/\/lens.org\/137-945-729-039-956","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T10:09:12Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-06-25T00:00:00Z","subj_id":"https:\/\/lens.org\/142-428-810-526-423","id":"c9e27db1-65e8-93c9-ab4f-d7bac9bdde82","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Lipidated Incretin Receptor Ligand Human Immunoglobulin Fc-Region Fusion Polypeptides","pid":"https:\/\/lens.org\/142-428-810-526-423","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T11:18:34Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-10-08T00:00:00Z","subj_id":"https:\/\/lens.org\/143-970-204-871-194","id":"d46dfad0-eb01-d9c0-1bbe-0a4704591d45","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For Detecting Multispecific Antibody Light Chain Mispairing","pid":"https:\/\/lens.org\/143-970-204-871-194","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T11:42:31Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-07-09T00:00:00Z","subj_id":"https:\/\/lens.org\/146-767-588-418-377","id":"44feb6ec-a336-1c6b-34c7-2d5c87fa6924","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Monovalent Blood Brain Barrier Shuttle Modules","pid":"https:\/\/lens.org\/146-767-588-418-377","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T12:25:45Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-14T00:00:00Z","subj_id":"https:\/\/lens.org\/150-342-033-203-12X","id":"d69ae5b2-f266-18d7-f41a-0223a714dcc3","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For The Selection Of Antibodies Against Bcma","pid":"https:\/\/lens.org\/150-342-033-203-12X","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T13:21:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-11-01T00:00:00Z","subj_id":"https:\/\/lens.org\/161-916-358-034-482","id":"07953d5c-3d5a-af35-3fee-e8c2eaf0e211","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"N-Terminal Acylated Polypeptides, Methods For Their Production And Uses Thereof","pid":"https:\/\/lens.org\/161-916-358-034-482","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T16:20:30Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-05-12T00:00:00Z","subj_id":"https:\/\/lens.org\/166-875-291-239-996","id":"e7430edb-773c-e1e5-9a5a-affdf5013204","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Amatoxin Derivatives And Conjugates Thereof As Inhibitors Of Rna Polymerase","pid":"https:\/\/lens.org\/166-875-291-239-996","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:45:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-07-15T00:00:00Z","subj_id":"https:\/\/lens.org\/167-365-146-545-619","id":"9c2d6b60-5ab8-24fe-69b2-faf20172b44d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Methods Of Generating Hybrid\/Chimeric Cells, And Uses Thereof","pid":"https:\/\/lens.org\/167-365-146-545-619","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-10T17:53:37Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-23T00:00:00Z","subj_id":"https:\/\/lens.org\/168-813-599-613-605","id":"81c587f2-fb6c-996e-c3ef-568c98e1ded9","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific, Tetravalent Antigen Binding Proteins","pid":"https:\/\/lens.org\/168-813-599-613-605","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T18:17:45Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-05-12T00:00:00Z","subj_id":"https:\/\/lens.org\/172-570-803-920-807","id":"28ce6178-4cdd-edcf-6af9-e8b06b367ea4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Glycosylated Repeat-Motif-Molecule Conjugates","pid":"https:\/\/lens.org\/172-570-803-920-807","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T19:22:09Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-12-17T00:00:00Z","subj_id":"https:\/\/lens.org\/175-067-224-030-747","id":"9fc2a98d-3f9a-dd33-c775-119df662ac30","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Auristatin Derivatives And Conjugates Thereof","pid":"https:\/\/lens.org\/175-067-224-030-747","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:05:38Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-06-25T00:00:00Z","subj_id":"https:\/\/lens.org\/177-372-840-383-515","id":"dbbf7ad4-1df9-78e4-88c2-a4f9d5910051","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Cytotoxic Peptides And Conjugates Thereof","pid":"https:\/\/lens.org\/177-372-840-383-515","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T20:44:33Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2007-04-26T00:00:00Z","subj_id":"https:\/\/lens.org\/183-194-052-129-194","id":"9e6aa326-36f2-273e-89ed-f4a6456dfe53","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For The Recombinant Expression Of A Polypeptide","pid":"https:\/\/lens.org\/183-194-052-129-194","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-10T22:22:46Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-10-08T00:00:00Z","subj_id":"https:\/\/lens.org\/190-616-457-515-254","id":"d1e5d8be-6259-6f73-3554-b7fb13fa06d2","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Multispecific Antibodies","pid":"https:\/\/lens.org\/190-616-457-515-254","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T00:29:12Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-03-10T00:00:00Z","subj_id":"https:\/\/lens.org\/191-301-131-935-902","id":"79f667a2-c844-66be-ae7b-d18a9a7911d5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Ox40L Antibodies","pid":"https:\/\/lens.org\/191-301-131-935-902","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T00:40:57Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-03-24T00:00:00Z","subj_id":"https:\/\/lens.org\/193-313-356-633-316","id":"9976b04f-3508-b15f-d137-e2427006ef66","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Cells For Transient Expression And Uses Thereof","pid":"https:\/\/lens.org\/193-313-356-633-316","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T01:14:41Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-01-29T00:00:00Z","subj_id":"https:\/\/lens.org\/196-144-035-258-53X","id":"10abcd7f-1612-964c-e7fb-e60c773b51ed","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"A Conjugate Of An Antibody Against Cd4 And Antifusogenic Peptides","pid":"https:\/\/lens.org\/196-144-035-258-53X","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T02:02:18Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-09-07T00:00:00Z","subj_id":"https:\/\/lens.org\/196-998-989-537-926","id":"a3df09ca-577b-48f5-cfc0-ac091c791d7a","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Monovalent Antigen Binding Proteins","pid":"https:\/\/lens.org\/196-998-989-537-926","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T02:17:18Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-08-11T00:00:00Z","subj_id":"https:\/\/lens.org\/199-951-244-423-351","id":"624ba653-e14a-428f-2c77-54068b18115f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Ox40L Antibodies","pid":"https:\/\/lens.org\/199-951-244-423-351","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T03:08:21Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-08-17T00:00:00Z","subj_id":"https:\/\/lens.org\/020-157-805-413-293","id":"7f1007da-db15-6132-6d2b-74384dd7a0b8","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-P-Selectin Antibodies","pid":"https:\/\/lens.org\/020-157-805-413-293","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T03:11:36Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-03-01T00:00:00Z","subj_id":"https:\/\/lens.org\/022-419-980-656-313","id":"94c1a260-347d-46cc-bafc-2b633edc11e4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Recombinant Fc-Fusion Protein Of The Fifth Fibronectin Type Iii Domain Of Dcc","pid":"https:\/\/lens.org\/022-419-980-656-313","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T03:48:04Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-06-23T00:00:00Z","subj_id":"https:\/\/lens.org\/025-590-937-916-641","id":"ec9d09f6-6755-30e6-d391-d7f7b166eef8","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Novel Methods For Enzyme Mediated Polypeptide Conjugation Using Sortase","pid":"https:\/\/lens.org\/025-590-937-916-641","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T04:36:32Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-04-05T00:00:00Z","subj_id":"https:\/\/lens.org\/027-830-271-425-397","id":"242377e5-1e47-435c-8f50-0332ab004dbd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Mammalian Expression System","pid":"https:\/\/lens.org\/027-830-271-425-397","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T05:11:20Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-10-15T00:00:00Z","subj_id":"https:\/\/lens.org\/028-560-329-337-330","id":"6e4771e2-2396-dca4-b901-23cfb21c110b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific Antibodies Against Cd3E And Ror1","pid":"https:\/\/lens.org\/028-560-329-337-330","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T05:22:36Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2009-06-10T00:00:00Z","subj_id":"https:\/\/lens.org\/031-383-131-436-548","id":"b8a8356d-735f-7321-f8a5-c06b5f2f424d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-P Selectin Antibodies","pid":"https:\/\/lens.org\/031-383-131-436-548","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T06:06:36Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-02T00:00:00Z","subj_id":"https:\/\/lens.org\/032-712-891-586-232","id":"a93becd9-8f1a-99e8-0c66-e2b5f54a5080","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Tri- Or Tetraspecific Antibodies","pid":"https:\/\/lens.org\/032-712-891-586-232","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T06:27:11Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-06T00:00:00Z","subj_id":"https:\/\/lens.org\/036-146-764-737-01X","id":"a88a9241-bb14-d8de-7659-040e8762c309","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For The Selection Of Antibodies Against Bcma","pid":"https:\/\/lens.org\/036-146-764-737-01X","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T07:20:01Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-11-28T00:00:00Z","subj_id":"https:\/\/lens.org\/045-730-720-264-029","id":"855690e1-7aa4-9d30-848b-3bd0aed400e4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"A Conjugate Of An Antibody Against Cd4 And Antifusogenic Peptides","pid":"https:\/\/lens.org\/045-730-720-264-029","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T09:48:39Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-04-02T00:00:00Z","subj_id":"https:\/\/lens.org\/004-776-899-950-841","id":"f632217e-2369-72f7-93bb-a0174a98a25c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific Antigen Binding Proteins","pid":"https:\/\/lens.org\/004-776-899-950-841","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:20:13Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-09-07T00:00:00Z","subj_id":"https:\/\/lens.org\/049-792-652-127-258","id":"df628704-c2c3-86a3-dac1-622863e2a33c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Antigen Binding Proteins","pid":"https:\/\/lens.org\/049-792-652-127-258","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:51:43Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2017-06-27T00:00:00Z","subj_id":"https:\/\/lens.org\/050-180-895-750-94X","id":"2660e9ed-424d-f718-8b25-575e2b17a9b0","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Single-Chain Antibodies And Other Heteromultimers","pid":"https:\/\/lens.org\/050-180-895-750-94X","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:57:42Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-05-28T00:00:00Z","subj_id":"https:\/\/lens.org\/050-203-744-371-511","id":"7871d311-2861-dd98-c02a-ab209cbcc759","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-Alpha-Synuclein Antibodies And Methods Of Use","pid":"https:\/\/lens.org\/050-203-744-371-511","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T10:58:09Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-05T00:00:00Z","subj_id":"https:\/\/lens.org\/051-284-715-332-787","id":"d9680b65-f249-5bea-7274-2a74a5d75206","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Tri- Or Tetraspecific Antibodies","pid":"https:\/\/lens.org\/051-284-715-332-787","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T11:15:22Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-06-07T00:00:00Z","subj_id":"https:\/\/lens.org\/054-698-550-982-018","id":"32cc239f-da72-0c13-065c-4f562e7bf97c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Methods Of Generating Hybrid\/Chimeric Cells, And Uses Thereof","pid":"https:\/\/lens.org\/054-698-550-982-018","jurisdiction":"KR"},"source_id":"cambia-lens","timestamp":"2017-11-11T12:09:38Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-07-12T00:00:00Z","subj_id":"https:\/\/lens.org\/059-382-180-750-447","id":"c83da323-505b-6e5e-9391-5169e9ccbcc6","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Modified Pseudomonas Exotoxin A","pid":"https:\/\/lens.org\/059-382-180-750-447","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T13:22:15Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-02-06T00:00:00Z","subj_id":"https:\/\/lens.org\/064-583-431-915-122","id":"c2bf2cb0-6157-c32f-241e-8e699ea4594e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Method For Producing Soluble Fcr As Fc-Fusion With Inert Immunoglobulin Fc-Region And Uses Thereof","pid":"https:\/\/lens.org\/064-583-431-915-122","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T14:42:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-09-02T00:00:00Z","subj_id":"https:\/\/lens.org\/066-259-755-148-917","id":"d3c6c6a9-accd-1e5c-e5d8-f83783ff9092","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Cells For Transient Expression And Uses Thereof","pid":"https:\/\/lens.org\/066-259-755-148-917","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T15:08:33Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-06T00:00:00Z","subj_id":"https:\/\/lens.org\/070-724-136-597-073","id":"0fed73bd-2cd1-5659-110f-e6dd6badf7a5","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific Antibodies Against Cd3Epsilon And Bcma","pid":"https:\/\/lens.org\/070-724-136-597-073","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T16:17:54Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-08-24T00:00:00Z","subj_id":"https:\/\/lens.org\/070-979-938-365-164","id":"58a171f0-b4aa-668e-04b7-57973ba43699","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-P-Selectin Antibodies","pid":"https:\/\/lens.org\/070-979-938-365-164","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T16:21:56Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-10-12T00:00:00Z","subj_id":"https:\/\/lens.org\/076-972-943-583-381","id":"b8732025-b41b-bb53-250b-c08d22d8dcb4","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-P-Selectin Antibodies","pid":"https:\/\/lens.org\/076-972-943-583-381","jurisdiction":"EP"},"source_id":"cambia-lens","timestamp":"2017-11-11T18:04:49Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-08-14T00:00:00Z","subj_id":"https:\/\/lens.org\/079-555-957-500-462","id":"3abe3d82-0fae-19bc-4505-2f53a05cbf9d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific Antibodies Against Cd3\u0395 And Bcma","pid":"https:\/\/lens.org\/079-555-957-500-462","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T18:48:00Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2005-10-27T00:00:00Z","subj_id":"https:\/\/lens.org\/084-301-633-715-96X","id":"07636a07-e4de-fabd-ae31-b17cc1644d88","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Anti-P-Selectin Antibodies","pid":"https:\/\/lens.org\/084-301-633-715-96X","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T20:08:31Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-05-31T00:00:00Z","subj_id":"https:\/\/lens.org\/084-479-884-797-822","id":"90f79531-b93d-89a4-cfc8-b4f30c3da65c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Conjugate Of An Antibody Against Ccr5 And An Antifusogenic Peptide","pid":"https:\/\/lens.org\/084-479-884-797-822","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T20:11:21Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2011-01-11T00:00:00Z","subj_id":"https:\/\/lens.org\/084-715-863-149-561","id":"1c480c72-3412-88e0-3242-d1240ed3e7a8","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Anti-Ox40L Antibodies","pid":"https:\/\/lens.org\/084-715-863-149-561","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T20:15:26Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2010-12-23T00:00:00Z","subj_id":"https:\/\/lens.org\/086-464-696-973-172","id":"9e5beed6-a61b-2819-0832-97088add7631","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Bispecific Antigen Binding Proteins","pid":"https:\/\/lens.org\/086-464-696-973-172","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T20:44:56Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2015-09-17T00:00:00Z","subj_id":"https:\/\/lens.org\/088-200-106-662-432","id":"9c56f373-2e3b-4f83-97f8-601bfab9f2f0","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Specific Sites For Modifying Antibodies To Make Immunoconjugates","pid":"https:\/\/lens.org\/088-200-106-662-432","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T21:14:07Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2004-08-12T00:00:00Z","subj_id":"https:\/\/lens.org\/093-455-029-299-240","id":"71b90036-a1d5-dcdd-9d29-965f02e4b160","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Search report","work_type_id":"patent","title":"Method For Protein Production","pid":"https:\/\/lens.org\/093-455-029-299-240","jurisdiction":"WO"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:43:41Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2016-07-05T00:00:00Z","subj_id":"https:\/\/lens.org\/093-960-599-975-471","id":"5906e0b4-7e4d-293e-7d60-282d1b451247","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Multispecific Antibodies Comprising Full Length Antibodies And Single Chain Fab Fragments","pid":"https:\/\/lens.org\/093-960-599-975-471","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:52:34Z","relation_type_id":"cites"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2019-04-24T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1080\/19420862.2019.1598230","id":"a5971e7c-2a62-428d-9105-dc7dcdbe3d5e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-06-22T09:09:06Z","relation_type_id":"references"},{"license":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","obj_id":"https:\/\/doi.org\/10.1002\/bit.1179","source_token":"8676e950-8ac5-4074-8ac3-c0a18ada7e99","occurred_at":"2012-03-14T00:00:00Z","subj_id":"https:\/\/doi.org\/10.1007\/s10616-012-9435-4","id":"f82ee369-4d35-4bd1-9cd4-530937ab7ccd","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","message_action":"create","source_id":"crossref","timestamp":"2019-06-26T03:20:24Z","relation_type_id":"references"}]}}